Collaborative care between endocrinologists, primary care providers, and other specialists ensures comprehensive management of these complex, interrelated conditions and optimizes both safety and therapeutic outcomes
Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, et al
Not because the disease is rare -type 1 diabetes with kidney involvement affects a large population - but because the eligibility window was incredibly tight: Type 1 diabetes (not type 2) Established CKD STILL albuminuric despite being on optimized standard of care Stable kidney function, controlled potassium, and a dozen other criteria Each added criterion shrinks the eligible pool dramatically
A one-unit error at this concentration equals 0.1 mg, which is 40% of the intended 0.25 mg starting dose
A 1,000 mg NAD+ vial may be mixed at different concentrations
Side Effects and Safety Considerations BPC-157 demonstrates an excellent safety profile across decades of animal research and extensive community use